Related references
Note: Only part of the references are listed.The contemporary landscape of occupational bladder cancer within the United Kingdom: a meta-analysis of risks over the last 80 years
Marcus G. Cumberbatch et al.
BJU INTERNATIONAL (2017)
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Sebastien Antoni et al.
EUROPEAN UROLOGY (2017)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2017)
Immunotherapy for the Treatment of Urothelial Carcinoma
Nicholas M. Donin et al.
JOURNAL OF UROLOGY (2017)
Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer
Daniel Ramirez et al.
BJU INTERNATIONAL (2016)
Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities
Kyle A. Richards et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer
Neema Navai et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World
Neda Mahdavifar et al.
Asian Pacific Journal of Cancer Prevention (2016)
Analysis of genetics to identify susceptibility to secondary malignancies in patients with bladder cancer
Yair Lotan
BJU INTERNATIONAL (2016)
Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study
Fredrik Liedberg et al.
BRITISH JOURNAL OF CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard et al.
CANCER CELL (2016)
Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
Philippe Lamy et al.
CANCER RESEARCH (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results
Seiji Naito et al.
EUROPEAN UROLOGY (2016)
Enhanced Recovery Pathways Versus Standard Care After Cystectomy: A Meta-analysis of the Effect on Perioperative Outcomes
Mark D. Tyson et al.
EUROPEAN UROLOGY (2016)
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
Jakub Dobruch et al.
EUROPEAN UROLOGY (2016)
Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
Ashish M. Kamat et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors
Norm D. Smith et al.
JOURNAL OF UROLOGY (2016)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Jaegil Kim et al.
NATURE GENETICS (2016)
ASCO endorses EAU muscle-invasive bladder cancer guidelines
Seth P. Lerner
NATURE REVIEWS UROLOGY (2016)
Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer
Aurelie Mbeutcha et al.
UROLOGIC CLINICS OF NORTH AMERICA (2016)
Surgical bladder-preserving techniques in the management of muscle-invasive bladder cancer
Matthew D. Lyons et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Recent Trends in Postcystectomy Health-related Quality of Life (QoL) Favors Neobladder Diversion: Systematic Review of the Literature
Anngona Ghosh et al.
UROLOGY (2016)
Complex systems analysis of bladder cancer susceptibility reveals a role for decarboxylase activity in two genome-wide association studies
Samantha Cheng et al.
BIODATA MINING (2016)
A Review Comparing Experience and Results with Bipolar Versus Monopolar Resection for Treatment of Bladder Tumors
Yasser Osman et al.
CURRENT UROLOGY REPORTS (2016)
Current Status of Robot-Assisted Radical Cystectomy and Intracorporeal Urinary Diversion
Raj Kurpad et al.
CURRENT UROLOGY REPORTS (2016)
Bipolar versus monopolar resection of benign prostate hyperplasia: a comparison of plasma electrolytes, hemoglobin and TUR syndrome
Meltem Savran Karadeniz et al.
SPRINGERPLUS (2016)
Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non-Small-Cell Lung Cancer A Review
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
Vipulkumar Dadhania et al.
EBIOMEDICINE (2016)
Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)
Nicholas E. Power et al.
BLADDER CANCER (2016)
Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study
Niccolo M. Passoni et al.
BLADDER CANCER (2016)
Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting
Seth P. Lerner et al.
BLADDER CANCER (2016)
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
Seth P. Lerner et al.
BLADDER CANCER (2016)
Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression
Guilherme Godoy et al.
BLADDER CANCER (2016)
Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life Instruments
Bernard J. Danna et al.
BLADDER CANCER (2016)
Claudin-low bladder tumors are immune infiltrated and actively immune suppressed
Jordan Kardos et al.
JCI INSIGHT (2016)
The proportion of cancer attributable to occupational exposures
Mark P. Purdue et al.
ANNALS OF EPIDEMIOLOGY (2015)
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update
Norm D. Smith et al.
BJU INTERNATIONAL (2015)
Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise
Jaegil Kim et al.
CLINICAL CANCER RESEARCH (2015)
Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review
Rowan G. Casey et al.
EUROPEAN UROLOGY (2015)
Systematic Review and Cumulative Analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Cystectomy
Giacomo Novara et al.
EUROPEAN UROLOGY (2015)
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial
Bernard H. Bochner et al.
EUROPEAN UROLOGY (2015)
Systematic Review and Cumulative Analysis of Oncologic and Functional Outcomes After Robot-assisted Radical Cystectomy
Bertram Yuh et al.
EUROPEAN UROLOGY (2015)
On Molecular Classification of Bladder Cancer: Out of One, Many
Mattias Aine et al.
EUROPEAN UROLOGY (2015)
Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer
Y. An et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Nonurothelial Bladder Cancer and Rare Variant Histologies
Daniel Willis et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
William Martin-Doyle et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Cora N. Sternberg et al.
LANCET ONCOLOGY (2015)
Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-BAIAP2L1
Yoshito Nakanishi et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma
Nirmish Singla et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
Faysal A. Yafi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma
Laimonis Kavalieris et al.
BMC UROLOGY (2015)
Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma
Mattias Aine et al.
GENOME MEDICINE (2015)
Options in metastatic urothelial cancer after first-line therapy
Nimira S. Alimohamed et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: A systematic review
Francesco Cantiello et al.
INTERNATIONAL JOURNAL OF UROLOGY (2015)
Biological determinants of bladder cancer gene expression subtypes
Mattias Aine et al.
SCIENTIFIC REPORTS (2015)
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Margaret A. Knowles et al.
NATURE REVIEWS CANCER (2015)
The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/Neu
Sungmi Jung et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base
Angela B. Smith et al.
BJU INTERNATIONAL (2014)
Bladder Cancer Collaborative Stage Variables and Their Data Quality, Usage, and Clinical Implications: A Review of SEER Data, 2004-2010
Mary E. Charlton et al.
CANCER (2014)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
Jeffrey S. Ross et al.
CLINICAL CANCER RESEARCH (2014)
Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
Yves Allory et al.
EUROPEAN UROLOGY (2014)
Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine
Carolyn D. Hurst et al.
EUROPEAN UROLOGY (2014)
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
Guillaume Ploussard et al.
EUROPEAN UROLOGY (2014)
Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non-Muscle-invasive Bladder Cancer
Jane M. Blazeby et al.
EUROPEAN UROLOGY (2014)
The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
Harman M. Bruins et al.
EUROPEAN UROLOGY (2014)
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Robert S. Svatek et al.
EUROPEAN UROLOGY (2014)
Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
Jeffrey J. Leow et al.
EUROPEAN UROLOGY (2014)
Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes
Claire F. Taylor et al.
HUMAN MOLECULAR GENETICS (2014)
Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012
Marie Ng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
A New Concept for Early Recovery after Surgery for Patients Undergoing Radical Cystectomy for Bladder Cancer: Results of a Prospective Randomized Study
A. Karl et al.
JOURNAL OF UROLOGY (2014)
Prospective External Validation of a Bladder Cancer Detection Model
Yair Lotan et al.
JOURNAL OF UROLOGY (2014)
Enhanced Recovery Protocol after Radical Cystectomy for Bladder Cancer
Siamak Daneshmand et al.
JOURNAL OF UROLOGY (2014)
Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen
Koji Izumi et al.
MOLECULAR CARCINOGENESIS (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Bladder cancers arise from distinct urothelial sub-populations
Jason Van Batavia et al.
NATURE CELL BIOLOGY (2014)
Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma
Kunyoo Shin et al.
NATURE CELL BIOLOGY (2014)
A new tumor suppressor role for the Notch pathway in bladder cancer
Theodoros Rampias et al.
NATURE MEDICINE (2014)
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Jeffrey S. Damrauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
Sandra Rebouissou et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Sex differences in incidence and mortality of bladder and kidney cancers: National estimates from 49 countries
Heather Donsky et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder
John P. Sfakianos et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Micropapillary bladder cancer: Current treatment patterns and review of the literature
Daniel L. Willis et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Extent of lymph node dissection and recurrence-free survival after radical cystectomy: A meta-analysis
Philipp Mandel et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
Eliezer M. Van Allen et al.
CANCER DISCOVERY (2014)
Androgen deprivation therapy prevents bladder cancer recurrence
Koji Izumi et al.
ONCOTARGET (2014)
Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer
Iver Nordentoft et al.
CELL REPORTS (2014)
Occupational and Environmental Exposures and Cancers in Developing Countries
Dana Hashim et al.
ANNALS OF GLOBAL HEALTH (2014)
Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients
Yasser Bayoumi et al.
CANCER MANAGEMENT AND RESEARCH (2014)
Toward a Molecular Pathologic Classification of Urothelial Carcinoma
Gottfrid Sjodahl et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS®) society recommendations
Yannick Cerantola et al.
CLINICAL NUTRITION (2013)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Immediate Post-Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non-Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review
Nathan Perlis et al.
EUROPEAN UROLOGY (2013)
Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Oncogenic FGFR3 gene fusions in bladder cancer
Sarah V. Williams et al.
HUMAN MOLECULAR GENETICS (2013)
Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study
Sarah E. Daugherty et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Measure once, cut twice-adding patient-reported outcome measures to the electronic health record for comparative effectiveness research
Albert W. Wu et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Pooled Analysis of Clinical Outcomes with Neoadjuvant Cisplatin and Gemcitabine Chemotherapy for Muscle Invasive Bladder Cancer
Bertram E. Yuh et al.
JOURNAL OF UROLOGY (2013)
Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guerin Failures in Nonmuscle Invasive Bladder Cancer
Colin P. N. Dinney et al.
JOURNAL OF UROLOGY (2013)
Perioperative Outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial of Open Versus Robotic Assisted Radical Cystectomy
Dipen J. Parekh et al.
JOURNAL OF UROLOGY (2013)
Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen-induced bladder carcinogenesis
Koji Izumi et al.
MOLECULAR CARCINOGENESIS (2013)
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
Guangwu Guo et al.
NATURE GENETICS (2013)
Frequent truncating mutations of STAG2 in bladder cancer
David A. Solomon et al.
NATURE GENETICS (2013)
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
Cristina Balbas-Martinez et al.
NATURE GENETICS (2013)
Stratifying Risk of Urinary Tract Malignant Tumors in Patients With Asymptomatic Microscopic Hematuria
Ronald K. Loo et al.
MAYO CLINIC PROCEEDINGS (2013)
Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
Carolyn D. Hurst et al.
CLINICAL CANCER RESEARCH (2012)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
Treatment Options Available for Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer
David R. Yates et al.
EUROPEAN UROLOGY (2012)
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma
Sandra Rebouissou et al.
JOURNAL OF PATHOLOGY (2012)
Does Partial Cystectomy Compromise Oncologic Outcomes for Patients with Bladder Cancer Compared to Radical Cystectomy? A Matched Case-Control Analysis
John J. Knoedler et al.
JOURNAL OF UROLOGY (2012)
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
Rodney Davis et al.
JOURNAL OF UROLOGY (2012)
Integrated Epigenome Profiling of Repressive Histone Modifications, DNA Methylation and Gene Expression in Normal and Malignant Urothelial Cells
Ewa Dudziec et al.
PLOS ONE (2012)
FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms
Darren C. Tomlinson et al.
PLOS ONE (2012)
Three differentiation states risk-stratify bladder cancer into distinct subtypes
Jens-Peter Volkmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations
Claire F. Snyder et al.
QUALITY OF LIFE RESEARCH (2012)
Genome Sequencing Identifies a Basis for Everolimus Sensitivity
Gopa Iyer et al.
SCIENCE (2012)
New Therapeutic Challenges in Advanced Bladder Cancer
Joaquim Bellmunt et al.
SEMINARS IN ONCOLOGY (2012)
Hypermethylation in bladder cancer: biological pathways and translational applications
Marta Sanchez-Carbayo
TUMOR BIOLOGY (2012)
Psychometric Characteristics of a Condition-specific, Health-related Quality-of-life Survey: The FACT-Vanderbilt Cystectomy Index
Christopher B. Anderson et al.
UROLOGY (2012)
Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Thomas Reinert et al.
CLINICAL CANCER RESEARCH (2011)
Enhanced recovery after surgery (ERAS) protocols: Time to change practice?
Megan Melnyk et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2011)
Association Between Smoking and Risk of Bladder Cancer Among Men and Women
Neal D. Freedman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
Celine Vallot et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization
Christina B. Ching et al.
MODERN PATHOLOGY (2011)
Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder
Kunyoo Shin et al.
NATURE (2011)
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Yaoting Gui et al.
NATURE GENETICS (2011)
A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
Gottfrid Sjodahl et al.
PLOS ONE (2011)
Ethnic Differences in Bladder Cancer Survival
David S. Yee et al.
UROLOGY (2011)
Altered Splicing of FGFR1 Is Associated with High Tumor Grade and Stage and Leads to Increased Sensitivity to FGF1 in Bladder Cancer
Darren C. Tomlinson et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Screening Adults for Bladder Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2010)
Pathological stage review is indicated in primary pT1 bladder cancer
Bas W. G. van Rhijn et al.
BJU INTERNATIONAL (2010)
High-Risk Patients With Hematuria Are Not Evaluated According to Guideline Recommendations
Keren Elias et al.
CANCER (2010)
Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue
Erika M. Wolff et al.
CANCER RESEARCH (2010)
Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome
David Lindgren et al.
CANCER RESEARCH (2010)
Genetic Susceptibility to Distinct Bladder Cancer Subphenotypes
Lin T. Guey et al.
EUROPEAN UROLOGY (2010)
Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort
Hans-Martin Fritsche et al.
EUROPEAN UROLOGY (2010)
Impact of Routine Second Transurethral Resection on the Long-Term Outcome of Patients with Newly Diagnosed pT1 Urothelial Carcinoma with Respect to Recurrence, Progression Rate, and Disease-Specific Survival: A Prospective Randomised Clinical Trial
Rauf Taner Divrik et al.
EUROPEAN UROLOGY (2010)
Prospective Randomized Controlled Trial of Robotic versus Open Radical Cystectomy for Bladder Cancer: Perioperative and Pathologic Results
Jeff Nix et al.
EUROPEAN UROLOGY (2010)
Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2010)
Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications
Matthias May et al.
EUROPEAN UROLOGY (2010)
Development and Validation of the Bladder Cancer Index: A Comprehensive, Disease Specific Measure of Health Related Quality of Life in Patients With Localized Bladder Cancer
Scott M. Gilbert et al.
JOURNAL OF UROLOGY (2010)
Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer
Eduardo Solsona et al.
JOURNAL OF UROLOGY (2010)
Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB Trial
Madelon N. M. van der Aa et al.
JOURNAL OF UROLOGY (2010)
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
Nathaniel Rothman et al.
NATURE GENETICS (2010)
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
Lambertus A. Kiemeney et al.
NATURE GENETICS (2010)
AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
J. M. Askham et al.
ONCOGENE (2010)
Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief?
David S. Aaronson et al.
BJU INTERNATIONAL (2009)
Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
Fiona M. Platt et al.
CLINICAL CANCER RESEARCH (2009)
Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies
Claudio Pelucchi et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2009)
Inactivation of p53 and Pten promotes invasive bladder cancer
Anna M. Puzio-Kuter et al.
GENES & DEVELOPMENT (2009)
Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication
Efstathios Kastritis et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumor Marker
Yair Lotan et al.
JOURNAL OF UROLOGY (2009)
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
Xifeng Wu et al.
NATURE GENETICS (2009)
Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner
E. di Martino et al.
ONCOGENE (2009)
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
Keith Syson Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The present and future burden of urinary bladder cancer in the world
Martine Ploeg et al.
WORLD JOURNAL OF UROLOGY (2009)
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy
Tadeusz Majewski et al.
LABORATORY INVESTIGATION (2008)
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
Lambertus A. Kiemeney et al.
NATURE GENETICS (2008)
The global burden of urinary bladder cancer
D. Maxwell Parkin
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2008)
p53 and retinoblastoma pathways in bladder cancer
Anirban P. Mitra et al.
WORLD JOURNAL OF UROLOGY (2007)
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
D. C. Tomlinson et al.
JOURNAL OF PATHOLOGY (2007)
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia
Sangkyou Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis
K. Takayama et al.
ONCOGENE (2007)
Adenoviral mediated interferon-α 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer
Liana Adam et al.
JOURNAL OF UROLOGY (2007)
Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis
Lan Mo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder
Johanna M. M. van Oers et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors
Elena Lopez-knowles et al.
CANCER RESEARCH (2006)
The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin:: A prospective, randomized clinical trial
RT Divrik et al.
JOURNAL OF UROLOGY (2006)
Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q
D Lindgren et al.
ONCOGENE (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Hormonal and reproductive factors and the risk of bladder cancer in women
M McGrath et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia
MS Kim et al.
LABORATORY INVESTIGATION (2006)
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
RJ Sylvester et al.
UROLOGY (2005)
Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines
DC Tomlinson et al.
CANCER RESEARCH (2005)
Bladder cancer stage and outcome by array-based comparative genomic hybridization
E Blaveri et al.
CLINICAL CANCER RESEARCH (2005)
Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor
J Palou et al.
JOURNAL OF UROLOGY (2005)
Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer
CJ Marsit et al.
CANCER RESEARCH (2005)
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
AH Jebar et al.
ONCOGENE (2005)
Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
H Abol-Enein et al.
EUROPEAN UROLOGY (2005)
Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial
G Velikova et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis
J Gao et al.
ONCOGENE (2004)
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2004)
Gene expression in the urinary bladder:: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
L Dyrskjot et al.
CANCER RESEARCH (2004)
Microscopic hematuria
RA Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses
EC Obermann et al.
JOURNAL OF PATHOLOGY (2003)
Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: A formal meta-analysis of comparative studies on recurrence and toxicity
A Bohle et al.
JOURNAL OF UROLOGY (2003)
Health-related quality-of-life assessments and patient-physician communication - A randomized controlled trial
SB Detmar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Frequent FGFR3 mutations in urothelial papilloma
BWG van Rhijn et al.
JOURNAL OF PATHOLOGY (2002)
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies
C Hafner et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer
R Simon et al.
ONCOGENE (2002)
Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor
L Cheng et al.
CANCER (2002)
Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium - An analysis of cytokeratin 20, p53, and CD44 antigens
JK McKenney et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression
A Kram et al.
LABORATORY INVESTIGATION (2001)
p53 mutations in urinary bladder cancer
P Berggren et al.
BRITISH JOURNAL OF CANCER (2001)
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors
C Billerey et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
JP Stein et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Aberrant expression of β-catenin and mutation of exon 3 of the β-catenin gene in renal and urothelial carcinomas
XD Zhu et al.
PATHOLOGY INTERNATIONAL (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study
DL Lamm et al.
JOURNAL OF UROLOGY (2000)
Share Paper
